Biased signaling by mutant EGFR underlies dependence on PKCα in lung adenocarcinoma.

Autor:	Sadeghi M; Department of Biochemistry, Stony Brook University, Stony Brook, NY 11794, USA; Stony Brook Cancer Center, Stony Brook University Hospital, Stony Brook, NY 11794, USA., Salama MF; Stony Brook Cancer Center, Stony Brook University Hospital, Stony Brook, NY 11794, USA; Department of Medicine, Stony Brook University, Stony Brook, NY 11794, USA; Department of Biochemistry, Faculty of Veterinary Medicine, Mansoura University, Mansoura 35516, Egypt., Chiappone SB; Stony Brook Cancer Center, Stony Brook University Hospital, Stony Brook, NY 11794, USA., Huang A; Stony Brook Cancer Center, Stony Brook University Hospital, Stony Brook, NY 11794, USA., Resnick AE; Stony Brook Cancer Center, Stony Brook University Hospital, Stony Brook, NY 11794, USA; Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY 11794, USA., Kandpal M; Centre for Clinical and Translational Science, Rockefeller University, New York, NY 10065, USA., Clarke CJ; Stony Brook Cancer Center, Stony Brook University Hospital, Stony Brook, NY 11794, USA; Department of Medicine, Stony Brook University, Stony Brook, NY 11794, USA., Haley JD; Stony Brook Cancer Center, Stony Brook University Hospital, Stony Brook, NY 11794, USA; Department of Pathology, Stony Brook University, Stony Brook, NY 11794, USA., Davuluri RV; Stony Brook Cancer Center, Stony Brook University Hospital, Stony Brook, NY 11794, USA; Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY 11794, USA., Hannun YA; Department of Biochemistry, Stony Brook University, Stony Brook, NY 11794, USA; Stony Brook Cancer Center, Stony Brook University Hospital, Stony Brook, NY 11794, USA; Department of Medicine, Stony Brook University, Stony Brook, NY 11794, USA; Department of Veterans Affairs, Northport VA Medical Center, Northport, NY 11768, USA. Electronic address: yusuf.hannun@stonybrookmedicine.edu.
Jazyk:	angličtina
Zdroj:	Cell reports [Cell Rep] 2024 Dec 03; Vol. 43 (12), pp. 115026. Date of Electronic Publication: 2024 Dec 03.
DOI:	10.1016/j.celrep.2024.115026
Abstrakt:	Activating mutations in the epidermal growth factor receptor (EGFR) promote ligand-independent signaling; however, the mechanisms involved are poorly defined, and it is unknown whether this generates specific vulnerabilities. We previously observed robust expression of protein kinase Cα (PKCα) in lung adenocarcinoma (LUAD) with mutant EGFR (mEGFR), which, unlike the activation of PKCα, is independent of mEGFR activity. Here, we identify a critical role for PKCα in anchorage-independent growth and survival of lung cancer cells with mEGFR. Mechanistically, signaling pathways initiated by mEGFR show a high preference for ligand-independent phosphorylation on Y992, resulting in biased activation and dependence on phospholipase-Cγ and PKCα. Moreover, through bioinformatic approaches, we find that mEGFR LUAD demonstrates a transcriptomic profile most similar to lung basal cells, which exhibit elevated levels of PKCα, suggesting that mEGFR tumors arise in cell types with high intrinsic levels of PKCα. Taken together, these findings explain the dependence of mEGFR on PKCα. Competing Interests: Declaration of interests The authors declare no competing interests. (Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu